141 related articles for article (PubMed ID: 16809897)
1. Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.
Barton Pai A; Pai MP; Depczynski J; McQuade CR; Mercier RC
Am J Nephrol; 2006; 26(3):304-9. PubMed ID: 16809897
[TBL] [Abstract][Full Text] [Related]
2. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
Pai AB; Conner T; McQuade CR; Olp J; Hicks P
Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
[TBL] [Abstract][Full Text] [Related]
3. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
Prakash M; Upadhya S; Prabhu R
Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
[TBL] [Abstract][Full Text] [Related]
4. Non-transferrin-bound iron in platelet concentrates promotes the growth of Staphylococcus epidermidis.
Matinaho S; Parkkinen J
Transfusion; 2005 Jun; 45(6):927-33. PubMed ID: 15934991
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
6. Bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrin-bound iron.
Matinaho S; Karhumäki P; Parkkinen J
Transfusion; 2005 Nov; 45(11):1768-73. PubMed ID: 16271102
[TBL] [Abstract][Full Text] [Related]
7. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients.
Driss F; Vrtovsnik F; Katsahian S; Michel C; Baron G; Kolta A; Sedrati N; Mentré F; Mignon F; Cabantchik I; Grandchamp B
Nephron Clin Pract; 2005; 99(3):c63-7. PubMed ID: 15640610
[TBL] [Abstract][Full Text] [Related]
9. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
Scheiber-Mojdehkar B; Lutzky B; Schaufler R; Sturm B; Goldenberg H
J Am Soc Nephrol; 2004 Jun; 15(6):1648-55. PubMed ID: 15153577
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
11. Common presence of non-transferrin-bound iron among patients with type 2 diabetes.
Lee DH; Liu DY; Jacobs DR; Shin HR; Song K; Lee IK; Kim B; Hider RC
Diabetes Care; 2006 May; 29(5):1090-5. PubMed ID: 16644642
[TBL] [Abstract][Full Text] [Related]
12. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.
Parkkinen J; von Bonsdorff L; Peltonen S; Grönhagen-Riska C; Rosenlöf K
Nephrol Dial Transplant; 2000 Nov; 15(11):1827-34. PubMed ID: 11071973
[TBL] [Abstract][Full Text] [Related]
13. Safety of intravenous injection of iron saccharate in haemodialysis patients.
Sunder-Plassmann G; Hörl WH
Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
[TBL] [Abstract][Full Text] [Related]
14. Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery.
Ambrus CM; Lajos TZ; Stadler I; Stadler A; Alfano J; Tulumello JA; Ambrus JL
J Med; 1999; 30(3-4):157-67. PubMed ID: 17312669
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
Charytan C; Levin N; Al-Saloum M; Hafeez T; Gagnon S; Van Wyck DB
Am J Kidney Dis; 2001 Feb; 37(2):300-7. PubMed ID: 11157370
[TBL] [Abstract][Full Text] [Related]
16. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males.
Schümann K; Kroll S; Romero-Abal ME; Georgiou NA; Marx JJ; Weiss G; Solomons NW
Ann Nutr Metab; 2012; 60(2):98-107. PubMed ID: 22398912
[TBL] [Abstract][Full Text] [Related]
17. Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications.
Belotti A; Duca L; Borin L; Realini S; Renso R; Parma M; Pioltelli P; Pogliani E; Cappellini MD
Leuk Res; 2015 Jan; 39(1):88-91. PubMed ID: 25435028
[TBL] [Abstract][Full Text] [Related]
18. Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform.
Jacobs EM; Hendriks JC; van Tits BL; Evans PJ; Breuer W; Liu DY; Jansen EH; Jauhiainen K; Sturm B; Porter JB; Scheiber-Mojdehkar B; von Bonsdorff L; Cabantchik ZI; Hider RC; Swinkels DW
Anal Biochem; 2005 Jun; 341(2):241-50. PubMed ID: 15907869
[TBL] [Abstract][Full Text] [Related]
19. Non-transferrin bound iron measurement is influenced by chelator concentration.
Kolb AM; Smit NP; Lentz-Ljuboje R; Osanto S; van Pelt J
Anal Biochem; 2009 Feb; 385(1):13-9. PubMed ID: 19026979
[TBL] [Abstract][Full Text] [Related]
20. Non-transferrin-bound iron in plasma following administration of oral iron drugs.
Dresow B; Petersen D; Fischer R; Nielsen P
Biometals; 2008 Jun; 21(3):273-6. PubMed ID: 17851733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
